Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing KangMu Omni-Honesty Animal Health Products is a prominent Chinese enterprise specializing in the animal health sector, operating as a key subsidiary of China Animal Husbandry Industry Co., Ltd. (CAHIC). The company is dedicated to the research, development, and production of a wide array of veterinary products, including vaccines, pharmaceuticals, and nutritional supplements for livestock and poultry. With state-of-the-art GMP-certified manufacturing facilities, it plays a vital role in the prevention and control of major animal diseases in China. Its product portfolio is designed to enhance animal welfare and productivity, serving the needs of the modern agricultural industry. The company leverages the extensive resources and distribution network of its parent group to maintain a strong market presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing KangMu Omni-Honesty Animal Health Products.